a Parallel, Randomised, Open-Label Clinical Trial Evaluating the Safety and Efficacy of Methotrexate With Apremilast in Patients With Moderate to Severe Palmoplantar Psoriasis. Int. J. Pharm. Sci. Lett. 2021, 11 (2), 1-11.